Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFα function with Etanercept in mdx mice

被引:178
作者
Hodgetts, Stuart [1 ]
Radley, Hannah [1 ]
Davies, Marilyn [1 ]
Grounds, Miranda D. [1 ]
机构
[1] Univ Western Australia, Sch Anat & Human Biol, Crawley, WA 6009, Australia
关键词
TNF alpha; Etanercept; neutrophils; muscular dystrophy; myofibre necrosis; therapy;
D O I
10.1016/j.nmd.2006.06.011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Necrosis of skeletal muscle fibres in the lethal childhood myopathy Duchenne Muscular Dystrophy results from deficiency of the cell membrane associated protein, dystrophin. We test the hypothesis in dystrophin-deficient mice, that the initial sarcolemmal breakdown resulting from dystrophin deficiency is exacerbated by inflammatory cells, specifically neutrophils, and that cytokines, specifically Tumour Necrosis Factor alpha (TNF alpha), contribute to myofibre necrosis. Antibody depletion of host neutrophils resulted in a delayed and significantly reduced amount of skeletal muscle breakdown in young dystrophic mdx mice. A more striking and prolonged protective effect was seen after pharmacological blockade of TNF alpha bioactivity using Etanercept. The extent of exercise induced myofibre necrosis in adult mdx mice after voluntarily wheel exercise was also reduced after Etanercept administration. These data show a clear role for neutrophils and TNF alpha in necrosis of dystrophic mdx muscle in vivo. Etanercept is a highly specific anti-inflammatory drug, widely used clinically, and potential application to muscular dystrophies is suggested by this reduced breakdown of mdx skeletal muscle. (C) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:591 / 602
页数:12
相关论文
共 65 条
[21]   Ventilatory dysfunction in mdx mice:: Impact of tumor necrosis factor-alpha deletion [J].
Gosselin, LE ;
Barkley, JE ;
Spencer, MJ ;
McCormick, KM ;
Farkas, GA .
MUSCLE & NERVE, 2003, 28 (03) :336-343
[22]  
Granchelli JA, 1996, RES COMMUN MOL PATH, V91, P287
[23]   Treatment of rheumatoid arthritis by TNF-blocking agents [J].
Graninger, W ;
Smolen, J .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2002, 127 (01) :10-14
[24]  
Grounds M D, 1993, Mol Cell Biol Hum Dis Ser, V3, P210
[25]   Anti-TNFα (Remicade®) therapy protects dystrophic skeletal muscle from necrosis [J].
Grounds, MD ;
Torrisi, J .
FASEB JOURNAL, 2004, 18 (06) :676-682
[26]   Silencing TNFα activity by using Remicade or Enbrel blocks inflammation in whole muscle grafts:: an in vivo bioassay to assess the efficacy of anti-cytokine drugs in mice [J].
Grounds, MD ;
Davies, M ;
Torrisi, J ;
Shavlakadze, T ;
White, J ;
Hodgetts, S .
CELL AND TISSUE RESEARCH, 2005, 320 (03) :509-515
[27]   The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy [J].
Haslbeck, KM ;
Friess, U ;
Schleicher, ED ;
Bierhaus, A ;
Nawroth, PP ;
Kirchner, A ;
Pauli, E ;
Neundörfer, B ;
Heuss, D .
ACTA NEUROPATHOLOGICA, 2005, 110 (03) :247-254
[28]   Clarifying the boundaries between the inflammatory and dystrophic myopathies: insights from molecular diagnostics and microarrays [J].
Hoffman, EP ;
Rao, D ;
Pachman, LM .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2002, 28 (04) :743-+
[29]   Expression of tumor necrosis factor-α in regenerating muscle fibers in inflammatory and non-inflammatory myopathies [J].
Kuru, S ;
Inukai, A ;
Kato, T ;
Liang, YD ;
Kimura, S ;
Sobue, G .
ACTA NEUROPATHOLOGICA, 2003, 105 (03) :217-224
[30]   INTERFERON-GAMMA PRIMES NEUTROPHIL-MEDIATED GASTRIC SURFACE CELL CYTOTOXICITY [J].
LIESER, MJ ;
KOZOL, RA ;
TENNENBERG, SD .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1995, 268 (05) :G843-G848